Morphomics predicts response to ipilimumab in patients with stage IV melanoma

E-ISSN： 1096-9098|22-4790|4|333-337

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.22-4790, Iss.4, 2015-08, pp. : 333-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Morphomics predicts response to ipilimumab in patients with stage IV melanoma

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 4, 2015-08 ,pp. : 333-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

When to Perform Surgery in Stage IV Melanoma Patients?

Oncology Research and Treatment, Vol. 31, Iss. 5, 2008-04 ,pp. : 226-227

Karger

Access to resources Recommend Favorite

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-05 ,pp. : 285-288

Karger

Access to resources Recommend Favorite

Ipilimumab‐induced hypophysitis in melanoma patients: an Australian case series

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1066-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin-2-Based Biochemotherapy for Patients with Stage IV Melanoma: Long-Term Survivors Outside a Clinical Trial Setting

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 33-40

Karger

Access to resources Recommend Favorite